关注
Daniel Schaefle
Daniel Schaefle
PhD Medical Microbiology, University of Zurich
在 imm.uzh.ch 的电子邮件经过验证
标题
引用次数
引用次数
年份
Evolution in action: habitat transition from sediment to the pelagial leads to genome streamlining in Methylophilaceae
MM Salcher, D Schaefle, M Kaspar, SM Neuenschwander, R Ghai
The ISME journal 13 (11), 2764-2777, 2019
882019
Identification of novel scaffolds targeting Mycobacterium tuberculosis
M Dal Molin, P Selchow, D Schäfle, A Tschumi, T Ryckmans, S Laage-Witt, ...
Journal of Molecular Medicine 97, 1601-1613, 2019
212019
Aquimarins, Peptide Antibiotics with Amino‐Modified C‐Termini from a Sponge‐Derived Aquimarina sp. Bacterium
CL Dieterich, SI Probst, R Ueoka, I Sandu, D Schäfle, MD Molin, ...
Angewandte Chemie 134 (8), e202115802, 2022
172022
Novel fidaxomicin antibiotics through site-selective catalysis
D Dailler, A Dorst, D Schäfle, P Sander, K Gademann
Communications Chemistry 4 (1), 59, 2021
152021
Rifabutin is inactivated by Mycobacterium abscessus Arr
D Schäfle, P Selchow, B Borer, M Meuli, A Rominski, B Schulthess, ...
Antimicrobial Agents and Chemotherapy 65 (3), 10.1128/aac. 02215-20, 2021
152021
DNA microarray-based characterization and antimicrobial resistance phenotypes of clinical MRSA strains from animal hosts
S Schmitt, R Stephan, E Huebschke, D Schaefle, A Merz, S Johler
Journal of veterinary science 21 (4), 2020
142020
Drug susceptibility distributions of Mycobacterium chimaera and other nontuberculous mycobacteria
B Schulthess, D Schäfle, N Kälin, T Widmer, P Sander
Antimicrobial Agents and Chemotherapy 65 (5), 10.1128/aac. 02131-20, 2021
112021
Synthesis and biological evaluation of iodinated fidaxomicin antibiotics
A Dorst, IS Shchelik, D Schäfle, P Sander, K Gademann
Helvetica Chimica Acta 103 (9), e2000130, 2020
112020
KatG as counterselection marker for nontuberculous mycobacteria
A Gagliardi, P Selchow, S Luthra, D Schäfle, B Schulthess, P Sander
Antimicrobial agents and chemotherapy 64 (5), 10.1128/aac. 02508-19, 2020
112020
The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex
NI Lorè, F Saliu, A Spitaleri, D Schäfle, F Nicola, DM Cirillo, P Sander
European Respiratory Journal 60 (6), 2022
92022
Evolution in action: Habitat-transition leads to genome-streamlining in Methylophilaceae (Betaproteobacteriales)
MM Salcher, D Schaefle, M Kaspar, SM Neuenschwander, R Ghai
bioRxiv, 651331, 2019
22019
Switching Residues: A Platform for the Synthesis of Fidaxomicin Antibiotics
E Jung, T Griesser, J Costafrolaz, O Duverger, Y Mattenberger, ...
Angewandte Chemie, e202419095, 2024
2024
Stress Response and Antibiotic Resistance in the Emerging Pathogen Mycobacterium Abscessus
D Schäfle
Universität Zürich, 2022
2022
Novel Fidaxomicin Antibiotics through Site-Selective Catalysis
D Dailler, A Dorst, D Schäfle, P Sander, K Gademann
ChemRxiv, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–14